The question about CYP1A2 and weight loss is understandable, as this gene regulates caffeine metabolism. However, the provided knowledge context contains no direct information on CYP1A2. In the general literature, rs762551 (CYP1A2*1F) is associated with caffeine metabolism: slow metabolizers (AA) have higher caffeine levels, which could theoretically influence thermogenesis and fat oxidation. The evidence for a clinically relevant effect on body weight is weak and inconsistent. Caffeine can transiently increase energy expenditure, but the effect is small and diminishes with regular use. Moreover, sleep disturbances or elevated blood pressure in slow metabolizers may have negative impacts. MyBody-X does not test CYP1A2 in its standard panel (per context). Therefore, personalized advice based on this gene is not currently evidence-based. Instead, proven strategies like calorie balance, adequate protein, and physical activity are key. Caution against excessive caffeine intake if slow metabolism is known.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-fc9981d4a954cd68c7f226b3